How are Indian CDMO companies changing their role in the pharmaceutical industry?

Indian CDMO companies are shifting from tactical manufacturing to forming strategic partnerships with global pharmaceutical firms.

What is the long-term growth outlook for India's CDMO sector?

The long-term growth outlook for India's CDMO sector is considered strong, with predictions of a multi-year growth cycle lasting 5-10 years.

Why are global pharmaceutical supply chains focusing on geographic diversification?

Global supply chains are focusing on geographic diversification due to geopolitical factors and risk management strategies.

Home / Business and Economy / India's CDMOs Shift to Strategic Partnerships

India's CDMOs Shift to Strategic Partnerships

18 Feb

•

Summary

Indian CDMOs are moving from manufacturing to strategic partnerships.
The long-term growth outlook for India's CDMO sector is strong.
Geopolitical shifts are driving global supply chain diversification.

India's CDMOs Shift to Strategic Partnerships

The Indian contract development and manufacturing (CDMO) sector is undergoing a significant structural transformation. Companies are evolving from purely tactical manufacturing roles to becoming strategic partners for global pharmaceutical firms. This shift is expected to fuel a multi-year growth cycle for the industry over the next five to ten years.

While short-term performance may exhibit quarterly fluctuations due to the inherent variability in molecule development and regulatory approvals, industry leaders emphasize a positive long-term growth outlook. Investors are advised to focus on the sustained development of capacity and customer relationships rather than short-term business indicators.